Ig therapy plays an important immunomodulatory role in incompatible organ transplantation with proven benefit for the desensitization of highly sensitized patients pre‐transplant to improve transplant rates and clinical outcomes. As the use of Ig therapy expands in this patient population, it is important to understand the differences in product formulations and composition in order to select the proper product for transplant patients.
Ashley Vo, PharmD, FAST
Nursing 1 contact hour
ACPE 1 contact hour
1 IgCN® / IgCP® Recertification Units